Di Xiao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Di Xiao has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Bao-Huan Zhang
Department of Epidemiology, School of Basic Medical Sciences, Jinan University, No.601 Huangpu Road West, Guangzhou 510632, Guangdong, China
2 shared publications - Chunxia Jing
Department of Epidemiology, School of Medicine, Jinan University, Guangzhou 510632, China
2 shared publications - Cong-Cong Guo
Department of Epidemiology, School of Basic Medical Sciences, Jinan University, No.601 Huangpu Road West, Guangzhou 510632, Guangdong, China
2 shared publications - Guang Yang
Department of Parasitology, School of Medicine, Jinan University, Guangzhou, Guangdong, China
2 shared publications Pei Wang
Department of Laboratory Medicine, Jingmen Central Hospital
2 shared publicationsQiong Wang
Department of Medicine, Jingmen Central Hospital Affiliated with Jingchu University of Technology
2 shared publications
Latest Publications
- 1 June 2026
- Published by Elsevier in Addictive Behaviors
- Vol. 181, 108759
Sleep traits, screen use, and emotional and behavioral problems: A short-term longitudinal cross-lagged panel network analysis
- 1 June 2026
- Published by Elsevier in Addictive Behaviors
- Vol. 181, 108759
Sleep traits, screen use, and emotional and behavioral problems: A short-term longitudinal cross-lagged panel network analysis
- Open Access
- 23 April 2026
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 16, 1785189
Early prediction of plastic bronchitis in pediatric patients with Mycoplasma pneumoniae pneumonia by interpretable machine learning algorithms
Background: Mycoplasma pneumoniae pneumonia (MPP) can cause plastic bronchitis (PB), a rare, life-threatening condition. However, current diagnostic methods often fail to identify early-stage PB in children.The aim of our study was to develop machine learning algorithms to identify early-stage PB in pediatric patients with MPP. Methods: This retrospective cohort study involved 307 pediatric patients with MPP who underwent bronchoscopy intervention from April 2023, to June 2025.Patients were randomly split into training and test sets (7:3). After feature selection using LASSO and Boruta algorithms, four algorithms, namely, extreme gradient boosting (XGBoost), logistic regression, random forest, and support vector machine, were employed to construct machine learning (ML) models through 5-fold cross-validation. Model performance was evaluated using the area under the curve (AUC), calibration curves, and decision curve analysis (DCA). The best-performing ML was selected using AUC, and feature importance in the model was ranked using SHapley Additive exPlanations (SHAP). Finally, a web-based risk predictor was constructed to facilitate user operability. Results: MPP children with PB demonstrated more significant abnormalities in inflammation- and nutrition-related indices compared to those without PB. The XGBoost algorithm exhibited the best predictive performance, surpassing other models (logistic regression, random forest, and support vector machine) with an AUC of 0.948 (95% CI: 0.919–0.973), a sensitivity of 0.904, and a specificity of 0.858 on the training set, and an AUC of 0.905 (95% CI: 0.843–0.957), a sensitivity of 0.812, and a specificity of 0.852 on the test set. This algorithm also presented good calibration and net clinical benefit. SHAP analysis identified the retinol-binding protein 4 level, M. pneumoniae cycle-threshold value, D-dimer level, fever duration before admission, C-reactive protein-to-albumin ratio, and presence of pleural effusion as key predictors. To facilitate the clinical adoption, a freely accessible online calculator has been developed ( https://plasticbronchitis.shinyapps.io/plastic_bronchitis_risk_calculator/ ). Conclusion: The developed interpretable ML models deployed in the network application can help clinicians identify children at high risk of developing PB earlier and tailor timely bronchoscopy intervention and nutritional support as well as anti-inflammatory therapy.
- 23 April 2026
- Published by Frontiers Media SA in Frontiers in Cellular and Infection Microbiology
- Vol. 16, 1785189
Open AccessEarly prediction of plastic bronchitis in pediatric patients with Mycoplasma pneumoniae pneumonia by interpretable machine learning algorithms
Background: Mycoplasma pneumoniae pneumonia (MPP) can cause plastic bronchitis (PB), a rare, life-threatening condition. However, current diagnostic methods often fail to identify early-stage PB in children.The aim of our study was to develop machine learning algorithms to identify early-stage PB in pediatric patients with MPP. Methods: This retrospective cohort study involved 307 pediatric patients with MPP who underwent bronchoscopy intervention from April 2023, to June 2025.Patients were randomly split into training and test sets (7:3). After feature selection using LASSO and Boruta algorithms, four algorithms, namely, extreme gradient boosting (XGBoost), logistic regression, random forest, and support vector machine, were employed to construct machine learning (ML) models through 5-fold cross-validation. Model performance was evaluated using the area under the curve (AUC), calibration curves, and decision curve analysis (DCA). The best-performing ML was selected using AUC, and feature importance in the model was ranked using SHapley Additive exPlanations (SHAP). Finally, a web-based risk predictor was constructed to facilitate user operability. Results: MPP children with PB demonstrated more significant abnormalities in inflammation- and nutrition-related indices compared to those without PB. The XGBoost algorithm exhibited the best predictive performance, surpassing other models (logistic regression, random forest, and support vector machine) with an AUC of 0.948 (95% CI: 0.919–0.973), a sensitivity of 0.904, and a specificity of 0.858 on the training set, and an AUC of 0.905 (95% CI: 0.843–0.957), a sensitivity of 0.812, and a specificity of 0.852 on the test set. This algorithm also presented good calibration and net clinical benefit. SHAP analysis identified the retinol-binding protein 4 level, M. pneumoniae cycle-threshold value, D-dimer level, fever duration before admission, C-reactive protein-to-albumin ratio, and presence of pleural effusion as key predictors. To facilitate the clinical adoption, a freely accessible online calculator has been developed ( https://plasticbronchitis.shinyapps.io/plastic_bronchitis_risk_calculator/ ). Conclusion: The developed interpretable ML models deployed in the network application can help clinicians identify children at high risk of developing PB earlier and tailor timely bronchoscopy intervention and nutritional support as well as anti-inflammatory therapy.
- Open Access
- 7 June 2025
- Published by Springer Nature in Italian Journal of Pediatrics
- Vol. 51 (1) , 1-11
Bronchoalveolar lavage cytokine profile and clinical features as risk predictors of plastic bronchitis in children with Mycoplasma pneumoniae pneumonia
Plastic bronchitis (PB), a condition in which mucus plugs block the bronchial tree, is a serious complication of Mycoplasma pneumoniae pneumonia (MPP). This study investigated whether clinical features and cytokine levels in bronchoalveolar lavage fluid (BALF) distinguish MPP from MPP complicated by PB and sought to identify risk factors for PB in children with MPP. A total of 128 children 3–14 years of age with MPP who underwent bronchoscopy at Jingmen Central Hospital, China, between 1 April 2023 and 31 March 2024 were enrolled. Patients were divided into a PB and a non-PB group based on bronchoscopy findings. Clinical manifestations and laboratory findings, including BALF cytokine levels, were compared. A risk prediction nomogram for PB was constructed and evaluated. Of 128 children with MPP, 40 (31%) had PB. Multivariate logistic regression analysis showed that clinically severe MPP (OR = 8.78; P = 0.002), systemic inflammatory response syndrome (SIRS) (OR = 2.78; P = 0.049) and elevated BALF interleukin-6 (IL-6) (OR = 1.01; P < 0.001) were independent risk factors for PB. The area under the receiver operating characteristic (ROC) curve (AUC) value for the combination of severe MPP, SIRS and IL-6 was 0.852 (95% confidence interval, 0.77–0.93). A calibration curve showed good agreement between nomogram prediction and actual observations (P = 0.723). A decision curve analysis indicated that the nomogram demonstrated good clinical applicability. Pronounced inflammatory responses and increased clinical severity of MPP are associated with PB. A nomogram that integrates clinical features and BALF IL-6 levels may be used for risk assessment and management of PB in MPP after initial bronchoscopy.
- 7 June 2025
- Published by Springer Nature in Italian Journal of Pediatrics
- Vol. 51 (1) , 1-11
Open AccessBronchoalveolar lavage cytokine profile and clinical features as risk predictors of plastic bronchitis in children with Mycoplasma pneumoniae pneumonia
Plastic bronchitis (PB), a condition in which mucus plugs block the bronchial tree, is a serious complication of Mycoplasma pneumoniae pneumonia (MPP). This study investigated whether clinical features and cytokine levels in bronchoalveolar lavage fluid (BALF) distinguish MPP from MPP complicated by PB and sought to identify risk factors for PB in children with MPP. A total of 128 children 3–14 years of age with MPP who underwent bronchoscopy at Jingmen Central Hospital, China, between 1 April 2023 and 31 March 2024 were enrolled. Patients were divided into a PB and a non-PB group based on bronchoscopy findings. Clinical manifestations and laboratory findings, including BALF cytokine levels, were compared. A risk prediction nomogram for PB was constructed and evaluated. Of 128 children with MPP, 40 (31%) had PB. Multivariate logistic regression analysis showed that clinically severe MPP (OR = 8.78; P = 0.002), systemic inflammatory response syndrome (SIRS) (OR = 2.78; P = 0.049) and elevated BALF interleukin-6 (IL-6) (OR = 1.01; P < 0.001) were independent risk factors for PB. The area under the receiver operating characteristic (ROC) curve (AUC) value for the combination of severe MPP, SIRS and IL-6 was 0.852 (95% confidence interval, 0.77–0.93). A calibration curve showed good agreement between nomogram prediction and actual observations (P = 0.723). A decision curve analysis indicated that the nomogram demonstrated good clinical applicability. Pronounced inflammatory responses and increased clinical severity of MPP are associated with PB. A nomogram that integrates clinical features and BALF IL-6 levels may be used for risk assessment and management of PB in MPP after initial bronchoscopy.
- Open Access
- 10 February 2017
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 14 (2) , 171
Association of LPP and TAGAP Polymorphisms with Celiac Disease Risk: A Meta-Analysis
Background: Lipoma preferred partner (LPP) and T-cell activation Rho GTPase activating protein (TAGAP) polymorphisms might influence the susceptibility to celiac disease. Therefore, we performed a meta-analysis by identifying relevant studies to estimate the risks of these polymorphisms on celiac disease. Methods: The PubMed, Web of Science and Embase databases were searched (up to October 2016) for LPP rs1464510 and TAGAP rs1738074 polymorphisms. Results: This meta-analysis included the same 7 studies for LPP rs1464510 and TAGAP rs1738074. The minor risk A allele at both rs1464510 and rs1738074 carried risks (odds ratios) of 1.26 (95% CI: 1.22–1.30) and 1.17 (95% CI: 1.14–1.21), respectively, which contributed to increased risks in all celiac disease patients by 10.72% and 6.59%, respectively. The estimated lambdas were 0.512 and 0.496, respectively, suggesting that a co-dominant model would be suitable for both gene effects. Conclusions: This meta-analysis provides robust estimates that polymorphisms in LPP and TAGAP genes are potential risk factors for celiac disease in European and American. Prospective studies and more genome-wide association studies (GWAS) are needed to confirm these findings, and some corresponding molecular biology experiments should be carried out to clarify the pathogenic mechanisms of celiac disease.
- 10 February 2017
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 14 (2) , 171
Open AccessAssociation of LPP and TAGAP Polymorphisms with Celiac Disease Risk: A Meta-Analysis
Background: Lipoma preferred partner (LPP) and T-cell activation Rho GTPase activating protein (TAGAP) polymorphisms might influence the susceptibility to celiac disease. Therefore, we performed a meta-analysis by identifying relevant studies to estimate the risks of these polymorphisms on celiac disease. Methods: The PubMed, Web of Science and Embase databases were searched (up to October 2016) for LPP rs1464510 and TAGAP rs1738074 polymorphisms. Results: This meta-analysis included the same 7 studies for LPP rs1464510 and TAGAP rs1738074. The minor risk A allele at both rs1464510 and rs1738074 carried risks (odds ratios) of 1.26 (95% CI: 1.22–1.30) and 1.17 (95% CI: 1.14–1.21), respectively, which contributed to increased risks in all celiac disease patients by 10.72% and 6.59%, respectively. The estimated lambdas were 0.512 and 0.496, respectively, suggesting that a co-dominant model would be suitable for both gene effects. Conclusions: This meta-analysis provides robust estimates that polymorphisms in LPP and TAGAP genes are potential risk factors for celiac disease in European and American. Prospective studies and more genome-wide association studies (GWAS) are needed to confirm these findings, and some corresponding molecular biology experiments should be carried out to clarify the pathogenic mechanisms of celiac disease.
- Open Access
- 30 March 2016
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 17 (4) , 457
Meta-Analysis on Associations of RGS1 and IL12A Polymorphisms with Celiac Disease Risk
The pathogenesis of celiac disease (CD) has been related to polymorphisms in the regulator of G-protein signaling 1 (RGS1) and interleukin-12 A (IL12A) genes, but the existing findings are inconsistent. Our aim is to investigate the associations of two single-nucleotide polymorphisms (SNPs) (rs2816316 in RGS1 and rs17810546 in IL12A) with CD risk using meta-analysis. We searched PubMed and Web of Science on RGS1 rs2816316 and IL12A rs17810546 with CD risk. Odds ratio (OR) and 95% confidence interval (CI) of each SNP were estimated. All statistical analyses were performed on Stata 12.0. A total of seven studies were retrieved and analyzed. The available data indicated the minor allele C of rs2816316 was negatively associated with CD (C vs. A: OR = 0.77, 95% CI = 0.74–0.80), and a positive association was found for the minor allele G of rs17810546 (G vs. A: OR = 1.37, 95% CI = 1.31–1.43). The co-dominant model of genotype effect confirmed the significant associations between RGS1 rs2816316/IL12A rs17810546 and CD. No evidence of publication bias was observed. Our meta-analysis supports the associations of RGS1 and IL12A with CD and strongly calls for further studies to better understand the roles of RGS1 and IL12A in the pathogenesis of CD.
- 30 March 2016
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 17 (4) , 457
Open AccessMeta-Analysis on Associations of RGS1 and IL12A Polymorphisms with Celiac Disease Risk
The pathogenesis of celiac disease (CD) has been related to polymorphisms in the regulator of G-protein signaling 1 (RGS1) and interleukin-12 A (IL12A) genes, but the existing findings are inconsistent. Our aim is to investigate the associations of two single-nucleotide polymorphisms (SNPs) (rs2816316 in RGS1 and rs17810546 in IL12A) with CD risk using meta-analysis. We searched PubMed and Web of Science on RGS1 rs2816316 and IL12A rs17810546 with CD risk. Odds ratio (OR) and 95% confidence interval (CI) of each SNP were estimated. All statistical analyses were performed on Stata 12.0. A total of seven studies were retrieved and analyzed. The available data indicated the minor allele C of rs2816316 was negatively associated with CD (C vs. A: OR = 0.77, 95% CI = 0.74–0.80), and a positive association was found for the minor allele G of rs17810546 (G vs. A: OR = 1.37, 95% CI = 1.31–1.43). The co-dominant model of genotype effect confirmed the significant associations between RGS1 rs2816316/IL12A rs17810546 and CD. No evidence of publication bias was observed. Our meta-analysis supports the associations of RGS1 and IL12A with CD and strongly calls for further studies to better understand the roles of RGS1 and IL12A in the pathogenesis of CD.